Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes

Running, not enrolling · Not applicable

Conditions studied: Cancer, Genetic Predisposition

In brief

This protocol aims to evaluate the efficacy of a theoretically and stakeholder informed patient-centered genetic Interactive Health Communication Application to increase patient understanding of, and affective and behavioral responses to genetic testing. The study investigators hypothesize that the intervention will be associated with increases in knowledge, decreases in distress, increases in communication with relatives and health care providers, and increases in performance of risk reducing health behaviors.

Key facts

Study ID

NCT04774445

Run by

Abramson Cancer Center at Penn Medicine

People needed

400

Starts

2021-05-03

Expected to finish

2026-04-01

Last updated by the study team

2025-02-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 18 years of age or older
• English Speaking
• Male or Female
• Internet and/or mobile access
• Previously received clinical genetic counseling and testing for hereditary cancer syndromes (up to 60 days prior to recruitment)

You may not qualify if…

• No internet and/or mobile access

Where it is running

• Abramson Cancer Center at the University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.